Life Sciences

• Foley Hoag Represents Kyruus in Acquisition of HealthSparq from Cambia Health Solutions

  January 11, 2021

• Foley Hoag Represents Pear Therapeutics, Inc. in $80M Series D Financing

  December 18, 2020

• Foley Hoag Expands Labor & Employment Practice in New York with Addition of Robert P. Haney Jr. as Partner

  December 7, 2020

• Foley Hoag Represents Organogenesis Holdings in $64.7M Follow-On Offering

  December 1, 2020

• Foley Hoag Partner Hemmie Chang Honored as 2020 Top Woman of Law by Massachusetts Lawyers Weekly

  November 18, 2020

• Foley Hoag Expands Licensing & Strategic Alliances Practice in New York with Addition of Marcus Sands as Counsel

  September 28, 2020

• Foley Hoag Represents Dogma Therapeutics in Sale of Its Oral PCSK9 Inhibitor Program to AstraZeneca

  September 17, 2020

• Foley Hoag Represents Glympse Bio in $46.7M Series B Financing

  July 23, 2020

• Foley Hoag Secures Court of Appeals Win for Dana-Farber Cancer Institute on Inventorship of Groundbreaking Cancer Immunotherapy Patents

  July 16, 2020

• Foley Hoag Advises RTW Investments and Ji Xing Pharmaceuticals on IP Matters in Royalty Monetization and Strategic Licensing Agreement with Cytokinetics for Up to $450 Million in Upfront and Milestone Payments

  July 15, 2020